Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03822468
Title Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer (PMR)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin + Letrozole + Ribociclib

Anastrozole + Ribociclib

Anastrozole + Goserelin + Ribociclib

Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.